2nd EORTC Symposium on Quality of Life Research Quality of Life, Symptom Research and Patient Reported Outcomes in Cancer Clinical Trials
This symposium aims to cover a broad range of topics in HRQOL, Symptom Research and Cancer clinical trials. It will address recent developments of EORTC tools, as well as other measures for use in clinical trials, but also have a broader focus including discussing international developments and research in oncology. The faculty are international key opinion leaders in their field who will be able to provide diverse opinions on HRQOL. All aspects of designing, conducting and analysing HRQOL in clinical trials will be discussed. In addition key EU legislators will interact with European patient groups to foster greater collaboration for advanced quality of life research.
Presentations
Introduction Academic and methodological issues
Key Note Address Academic and methodological issues
Basics of design and analysis of HRQOL protocols Academic and methodological issues
How to make a HRQOL Measure the EORTC way: New Developments Academic and methodological issues
HRQOL in daily practice – Experience with EORTC tools Methodology of trials with HRQOL issues
Does it make sense to assess HRQOL in brain cancer Methodology of trials with HRQOL issues
Do medical journals understand PRO and QOL Methodology of trials with HRQOL issues
Complex analysis strategies for longitudinal data Understanding optimal analysis of HRQOL data techniques for cancer clinical trials
Cluster Analysis: Can it Add to your Data? Understanding optimal analysis of HRQOL data techniques for cancer clinical trials
Fatigue: Can we measure it in cancer clinical trials? Understanding optimal analysis of HRQOL data techniques for cancer clinical trials
Using HRQOL data in economic analysis: Mapping the methodological minefield Understanding optimal analysis of HRQOL data techniques for cancer clinical trials
Genetics and HRQOL - Related or not - Pro Debate
Genetics and HRQOL - Related or not - Con Debate
Genetics and HRQOL - Related or not Discussion
Why HRQOL is important to patients Patients and Regulatory Views of HRQOL
Getting Patients Included in Clinical Trials Patients and Regulatory Views of HRQOL
Getting Patients Included in Clinical Trials Patients and Regulatory Views of HRQOL
Getting Patients Included in Clinical Trials Patients and Regulatory Views of HRQOL
What do companies do with the FDA PRO guidance? Patients and Regulatory Views of HRQOL
The Added Value of QOL in Clinical Trials: NCIC-CTG Experience International Cooperative Groups and HRQOL (Lessons Learned)
EORTC experience and success in cancer clinical trials International Cooperative Groups and HRQOL (Lessons Learned)
Biases in assessing patient-reported outcomes International Cooperative Groups and HRQOL (Lessons Learned)
Measuring changes in symptom status and QOL: Group vs individual level assessment International Cooperative Groups and HRQOL (Lessons Learned)
Translations and HRQOL: What is the best approach? Translations and the Future for HRQOL
Minimum Clinically Important Change in QOL based on Clinical Anchors Translations and the Future for HRQOL
Quality of Life in elderly cancer patients Translations and the Future for HRQOL
Quality of Life Tools for Elderly Patients Translations and the Future for HRQOL
Looking back to go ahead Translations and the Future for HRQOL
Farewell address and symposium evaluation
Infos
| Date | September 07, 2011 - September 09, 2011 |
|---|---|
| Program-Link: | http://www.eortc.be/probe/documents/QoL_Symposium2011_FinalProgramme.pdf |
| Website: | http://www.eortc.be/probe/ |
| Location: | European Parliament; |
| Category: | Medicine; |
Partner Societies
ISOQOL's New Newsletter
Latest Presentations
Videos are not working? If the videos are not working on your computer, make sure you have installed the latest Flash Player and javascript is enabled in your browser.
Latest Congresses
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our Terms of use. Warning: Some websites may contain content of an adult nature. These pages are designed for ADULTS only.